Hyebin Koh
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dual-mode SOX2 regulation by miR-150 via mRNA suppression and autophagy controls stem cell fate.
Journal: Signal transduction and targeted therapy
Published: October 15, 2025
Orai1 acts as a novel Ca2+ signal switch, balancing erythropoiesis through KLF1 regulation.
Journal: Experimental & molecular medicine
Published: July 23, 2025
Endoglin Regulates Pluripotency and Differentiation in Human Embryonic Stem Cells Through Wnt and TGF-β Signaling Crosstalk.
Journal: Journal of cellular physiology
Published: April 10, 2025
Temporal Regulation of Cytokines and Growth Factors for Optimized Hematopoietic-Lineage Specification from Human Pluripotent Stem Cells.
Journal: International journal of stem cells
Published: March 19, 2025
Mitochondrial dysfunction by glyoxalase 1 deficiency disrupts definitive endoderm and alveolar development of human pluripotent stem cells.
Journal: Experimental & molecular medicine
Published: November 03, 2024
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT).
Journal: Cell & bioscience
Published: February 10, 2024
Ferric citrate and apo-transferrin enable erythroblast maturation with β-globin from hemogenic endothelium.
Journal: NPJ Regenerative medicine
Published: November 22, 2022
Maintenance of Hypoimmunogenic Features via Regulation of Endogenous Antigen Processing and Presentation Machinery.
Journal: Frontiers in bioengineering and biotechnology
Published: May 05, 2022
Generation of induced pluripotent stem cell line (KRIBBi004-A) from adult bone marrow CD34+ cells from a patient carrying 46,XX,t(1;5)(p31.1;35.1) karyotype.
Journal: Stem cell research
Published: September 27, 2021
Human Blood Vessel Organoids Penetrate Human Cerebral Organoids and Form a Vessel-Like System.
Journal: Cells
Published: July 09, 2021
Establishment of iPSC (KRIBBi001-A) from CD34+ group O D-negative bone marrow blood.
Journal: Stem cell research
Published: January 07, 2021
Last Updated: 09/26/2026